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Introduction
The differential diagnosis between benign and malignant 
parotid lesions cannot be established by the simple physi-
cal examination but requires complementary diagnostic 
methods.
Fine-needle aspiration cytology (FnAC) guided by ultra-
sound imaging (US) is a widely used diagnostic tool to 
evaluate both neoplastic and inflammatory lesions of the 
salivary glands.
FnAC became popular 30 years ago 1 as it is useful in the 
differential diagnosis of salivary gland swellings. it is a mini-
mally invasive procedure that does not require anaesthesia 2. 
it is well-tolerated, simple, safe and cost-effective 3 4. More-
over, it can be easily repeated in the event of non-diagnostic 
results, thus improving diagnostic precision 5.
nevertheless, the role of FnAC in the pre-operative evalu-
ation is not universally established. At present, the debate 
focuses on the reliability of FnAC as a diagnostic tool and 
its usefulness in treatment planning. Although in some 
hospitals, FnAC is performed in every case of salivary 
gland nodule, some Authors support the role of cytology 
only in a selected group of patients with suspected ma-
lignancy, metastatic carcinoma or lymphoma 6. however, 
Butsakis et al. state that pre-surgical FnAC does not im-
pact on the surgical handling of these lesions7.
The aim of the present investigation was to assess the di-
agnostic accuracy of FnAC, on parotid gland swellings, 
in order to determine its usefulness in the planning of pa-
rotid gland surgery.
Material and methods
A  retrospective  study  was  carried  out  focused  on  176 
consecutive patients affected by parotid disease that were 
referred to the Department of otorhinolaryngology, “San 
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riASSUnTo
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raffaele” Scientific institute, Milan (italy), between Feb-
ruary 2002 and February 2008.
The  retrospective  review  of  case  notes  was  performed 
maintaining an anonymous evaluation of the data. The 
study protocol is in accordance with the helsinki Decla-
ration of 1975, as revised in 1983.
All patients underwent FnAC under US guidance follow-
ing clinical examination. in order to obtain homogeneous 
and comparable data, only FnAC performed in our insti-
tute were considered. All details regarding demographic 
and clinical data, including age, sex, previous surgery, 
timing of symptoms, cytological and histological results, 
site and volume of the lesions, involvement of histological 
sample margins and relapses were saved in an electronic 
database.
in our institute, FnAC is always performed by radiolo-
gists under US-guidance (with the use of a 23-gauge nee-
dle). Cytology is performed in all cases by the same pa-
thologist.
The cytological results were classified as: “inflammatory/
benign lesion”, “malignant neoplasm”, or “non-diagnos-
tic” when the cytological analysis was inconclusive.
A statistical analysis was performed with the specific soft-
ware JMP in 5.1 (a Business Unit of SAS Copyright ©1989 
-2003 SAS institute inc., Cary, nC, USA). Sensitivity, Spe-
cificity, Accuracy, Positive Predictive value (PPv), nega-
tive Predictive value (nPv), likelihood ratio of Positive 
test results (lr+), likelihood ratio for negative test results 
(lr-) and Prevalence of Malignancies were calculated for 
FnAC by using the post-operative histological diagnosis as 
the reference standard. Kappa statistics for agreement were 
also calculated together with the 95% confidence interval 
(95% Ci).
Results
FnAC samples were obtained in 176 cases. FnAC results 
were “non-diagnostic” in 36 cases (20.45%), “inflamma-
tory/benign  lesion”  in  126  (71.59%),  “malignant  neo-
plasm” in 14 (7.95%) (Table i). The cytological diagnosis 
in this series is reported in Table ii.
The correlation between the cytological and histopatho-
logical diagnosis was assessed in the 140 patients with a 
diagnostic FnAC (Table iii).
The most common histopathological diagnosis was “be-
nign lesion”, that occurred in 124 patients (88.57%) and 
included pleomorphic adenoma in 81 patients (57.85%) 
and warthin’s tumour in 42 (30%). Mucoepidermoid car-
cinoma (2.85%) was the most common malignancy, fol-
lowed  by  adenocarcinoma  (2.14%)  and  squamous  cell 
carcinoma (2.14%).
FnAC showed a sensitivity of 81% and a specifity of 
99%. Accuracy for malignancy was 97%, accuracy for a 
benign lesion was 83%, overall diagnostic accuracy was 
97%. The FnAC PPv for malignancy was 93% and the 
nPv was 98%. The likelihood ratio of Positive test re-
sults was 100.3 and the likelihood ratio of negative test 
results was 0.19, where “positive” was meant as “malig-
nant”. The prevalence of malignancy was 0.114.
Kappa statistics for the degree of agreement between 
FnAC  and  histological  examinations  was  0.85  (95% 
Ci = 0.71-0.99) (Table iv).
Discussion
Most publications focus attention on the efficacy of FnAC 
but at present, there is no consensus regarding its effective 
role in the diagnostic work-up of parotid masses 6 8.
in our Department, FnAC is performed in every case of 
parotid lesion, benign or malignant, palpable or not, in or-
der to correctly plan surgery. The most important goal of 
this examination is to distinguish a benign, from a malig-
Table I. The FNAC results classification.
Diagnosis FNAC no. (%) Histology no. (%)
Benign/Inflammatory 
lesions
 126 (71.59%) 124 (70.45%)
Malignant tumours 14   (7.95%)   16   (9.09%)
Non Diagnostic 36 (20.45%)   19 (10.79%) benign 
                      lesions
    6   (3.40%) malignant
                      tumours
Table II. Cytodiagnosis of salivary gland tumours by aspiration biopsy.
Lesion  No. cases Percentage
Pleomorphic adenoma  81 57.8%
Warthin’s tumour 42 30.1% 
Mucoepidermoid carcinoma 4 2.9% 
Adenocarcinoma 3 2.1% 
Indifferentiated carcinoma  3 2.1%
Lymphoma 2 1.5%
Adenoid cystic carcinoma 1 0.7%
Ductal adenoma  1 0.7% 
Oncocytoma  1 0.7% 
Monomorphic adenoma  1 0.7% 
Lipoma  1 0.7% 
140 100%
Table III. Contingency table between cytologic and histologic diagnosis.
Parotid 
FNAC
Benign 
histology
Malignant 
histology
Total
Benign
FNAC
123
97.62
3
2.38
126
Malignant
FNAC
1
7.14
13
92.86
14
Total 124 16 140Fine-needle aspiration cytology in the diagnosis of parotid lesions
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nant mass. 20.6% of FnAC are non-diagnostic; this could 
be due to the complexity of the tissue architecture.
in the recent scientific literature, sensitivity ranges from 
57% to 98%, specificity from 56% to 100%, and accuracy 
from 78% to 98% 1 5 6 9-17. Different causes could account 
for this variability. it is difficult to compare data from dif-
ferent studies because of the different methods adopted to 
classify patients, exams and results.
in many papers, cytological and histological results ob-
tained from both parotid and submandibular glands are 
analysed together. Moreover, sensitivity, specificity and 
accuracy are sometimes calculated for each single his-
tological subtype, such as pleomorphic adenoma or mu-
coepidermoid carcinoma. in some studies, patients under-
went FnAC only in cases of suspected malignancy and 
this clearly affects sensitivity, specificity and accuracy. 
on the contrary, in other studies, FnAC is performed rou-
tinely and the rate of malignancies is very low 6.
Some Authors highlighted the potential for false-negative 
FnAC  9  11  14.  in  the  retrospective  study  reported Atula 
et al. 11, diagnosis of mucoepidermoid carcinoma, adenoid 
cystic  carcinoma,  lymphoma  and  squamous  cell  carci-
noma was frequently missed by FnAC alone. in our se-
ries, FnAC false-negative findings occurred in one case 
of acinic cell carcinoma, in one of mucoepidermoid car-
cinoma and in one of lymphoma. in all of these cases, 
the cytological diagnosis was warthin’s tumour. Que hee 
et al. 15 reported a low accuracy of FnAC (56%), but the 
specimens were collected by several different clinicians 
with varying degrees of experience and not by patholo-
gists. in fact, the FnAC result depends both on the opera-
tor’s experience and the diagnostic skill of the cytopathol-
ogist. good collaboration between the clinician and the 
pathologist guarantees the best results.
in some studies on the parotid gland, FnAC PPv and 
nPv have been calculated: these values varied consider-
ably between the different studies. The low value of nPv 
reported by Cohen et al. 6 means that more than half of the 
FnAC specimens, without neoplastic cells, were actually 
obtained from neoplastic lesions, as assessed by histol-
ogy. in agreement with our results, Zurrida et al. reported 
both a high PPv and a high nPv (of 100% and 90%, re-
spectively) 9.
The results of the likelihood ratio of positive and negative 
were 100.3 and 0.19, respectively. This means that FnAC 
can be considered useful in predicting the histopathologi-
cal diagnosis of the parotid masses.
Kappa statistics for the degree of agreement between FnAC 
and histological examinations was 0.85 (95% Ci = 0.707-
0.993), which means that the agreement lies between sub-
stantial and almost perfect (Table iv).
Conclusions
FnAC  is  a  well-established  tool  to  investigate  parotid 
swellings but its role still remains controversial. our data 
support the hypothesis that FnAC is effective in this set-
ting. Moreover, FnAC may be considered safe. good col-
laboration between the clinician and the pathologist is, in 
our opinion, important to obtain the best results.
Table IV. Evaluation of the usefulness of FNAC.
Value, % 95% Confidence 
Interval
Sensitivity 81
Specificity 99
Positive Predictive Value (PPV) 93
Negative Predictive Value (NPV) 98
Likelihood Ratio for Positive test 
results
100.3
Likelihood Ratio for Negative 
test results
0.19
Kappa 0.85 0.707 – 0.993
Prevalence of malignancies 0.1143
Prevalence of benign findings 0.8857
Accuracy for malignancy 97
Accuracy for benign findings 83
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